Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI029168-07A1
Application #
2064858
Study Section
AIDS and Related Research Study Section 2 (ARRB)
Project Start
1989-09-30
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Washington
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Fleming, Thomas R; Ellenberg, Susan S; DeMets, David L (2018) Data Monitoring Committees: Current issues. Clin Trials 15:321-328
Chung, Yunro; Ivanova, Anastasia; Hudgens, Michael G et al. (2018) Partial likelihood estimation of isotonic proportional hazards models. Biometrika 105:133-148
Wakefield, Jon; Fuglstad, Geir-Arne; Riebler, Andrea et al. (2018) Estimating under-five mortality in space and time in a developing world context. Stat Methods Med Res :962280218767988
Scott, JoAnna M; deCamp, Allan; Juraska, Michal et al. (2017) Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials. Stat Methods Med Res 26:583-597
Fleming, Thomas R; DeMets, David L; Roe, Matthew T et al. (2017) Data monitoring committees: Promoting best practices to address emerging challenges. Clin Trials 14:115-123
Gao, Fuchang; Wellner, Jon A (2017) Entropy of Convex Functions on ? d . Constr Approx 46:565-592
Wellner, Jon A (2017) The Bennett-Orlicz Norm. Sankhya Ser A 79:355-383
Halloran, M Elizabeth; Auranen, Kari; Baird, Sarah et al. (2017) Simulations for designing and interpreting intervention trials in infectious diseases. BMC Med 15:223
Jiang, Runchao; Lu, Wenbin; Song, Rui et al. (2017) DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY. Ann Appl Stat 11:1763-1786
Fleming, Thomas R; DeMets, David L; Roe, Matthew T et al. (2017) Rejoinder. Clin Trials 14:126-127

Showing the most recent 10 out of 129 publications